UNIPHAR PLC (UPR.I) Stock Price & Overview
DUB:UPR • IE00BJ5FQX74
Current stock price
The current stock price of UPR.I is 3.675 EUR. Today UPR.I is down by -1.08%. In the past month the price decreased by -10.15%. In the past year, price increased by 31.72%.
UPR.I Key Statistics
- Market Cap
- 953.92M
- P/E
- 14.70
- Fwd P/E
- 14.31
- EPS (TTM)
- 0.25
- Dividend Yield
- 0.87%
UPR.I Stock Performance
UPR.I Stock Chart
UPR.I Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to UPR.I. When comparing the yearly performance of all stocks, UPR.I is one of the better performing stocks in the market, outperforming 78.44% of all stocks.
UPR.I Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to UPR.I. There are concerns on the financial health of UPR.I while its profitability can be described as average.
UPR.I Earnings
On February 24, 2026 UPR.I reported an EPS of 0.15 and a revenue of 1.59B. The company beat EPS expectations (4.59% surprise) and missed revenue expectations (-1.23% surprise).
UPR.I Forecast & Estimates
12 analysts have analysed UPR.I and the average price target is 4.93 EUR. This implies a price increase of 34.18% is expected in the next year compared to the current price of 3.675.
For the next year, analysts expect an EPS growth of 5.5% and a revenue growth 4.61% for UPR.I
UPR.I Groups
Sector & Classification
UPR.I Financial Highlights
Over the last trailing twelve months UPR.I reported a non-GAAP Earnings per Share(EPS) of 0.25. The EPS increased by 20.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.66% | ||
| ROA | 2.95% | ||
| ROE | 12.61% | ||
| Debt/Equity | 1.21 |
UPR.I Ownership
UPR.I Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| AXNA | AMPLIFON SPA | 12.73 | 2.052B | ||
| AMP | AMPLIFON SPA | 12.68 | 2.037B | ||
| FAGR | FAGRON | 13.94 | 1.577B | ||
| ILM1 | MEDIOS AG | 8.62 | 299.487M | ||
| BLC | BASTIDE LE CONFORT MEDICAL | 12.42 | 169.878M | ||
| VME | VIROMED MEDICAL AG | N/A |
Related stock screener links
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Dublin Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About UPR.I
Company Profile
Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. The firm is focused on improving access to pharmaco-medical products and therapies. The company operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution, and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland. The company operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. The company also provides services and support that help independent community pharmacies.
Company Info
IPO: 2019-07-17
UNIPHAR PLC
4045 Kingswood Road, Citywest Business Park
DUBLIN DUBLIN IE
Employees: 3500
Phone: 35314687501
UNIPHAR PLC / UPR.I FAQ
Can you describe the business of UNIPHAR PLC?
Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. The firm is focused on improving access to pharmaco-medical products and therapies. The company operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution, and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland. The company operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. The company also provides services and support that help independent community pharmacies.
What is the stock price of UNIPHAR PLC today?
The current stock price of UPR.I is 3.675 EUR. The price decreased by -1.08% in the last trading session.
Does UPR stock pay dividends?
UNIPHAR PLC (UPR.I) has a dividend yield of 0.87%. The yearly dividend amount is currently 0.02.
How is the ChartMill rating for UNIPHAR PLC?
UPR.I has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the valuation of UNIPHAR PLC (UPR.I) based on its PE ratio?
The PE ratio for UNIPHAR PLC (UPR.I) is 14.7. This is based on the reported non-GAAP earnings per share of 0.25 and the current share price of 3.675 EUR.
Should I buy UPR stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on UPR.I.